Market Cap (In EUR)
126.51 Million
Revenue (In EUR)
50.92 Million
Net Income (In EUR)
1.87 Million
Avg. Volume
61.8 Thousand
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.706-1.01
- PE
- -
- EPS
- -
- Beta Value
- 0.953
- ISIN
- GRS246003008
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Vassilis Baloumis
- Employee Count
- -
- Website
- https://lavipharm.com
- Ipo Date
- 1995-11-08
- Details
- Lavipharm S.A. engages in the research, development, manufacturing, import, marketing, sale, and wholesaling of pharmaceutical, dermocosmetic, and healthcare products in Greece and internationally. The company offers pharmaceutical products for cardiology, chronic pain and oncology, central nervous system, general medicine, gastrointestinal system, and urology; and over the counter (OTC) drugs, such as antiseptics, anagelsics, and anti-lice treatment products. It also provides a range of skincare products. The company was founded in 1911 and is based in Paiania, Greece.
More Stocks
-
300345
-
BTAFF
-
6806
-
6666
-
OVLYOak Valley Bancorp
OVLY
-
CTPNVCTP N.V.
CTPNV
-
2327
-
UCASUUC Asset, LP
UCASU